2 completed, 2 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Unknown 2 |
Follow Lead: new trials by email Literature Review of Lead trials Research Report on Lead
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test Pre and post-CPB Drug: Dobutamine Hydrochloride, Post-CPB Drug: Dobutamine Hydrochloride - Hypertrophic Obstructive Cardiomyopathy | Phase 4 | Unknown | University Health Network, Toronto | 60 | 2023-03-01 | 2022-11-08 |
| The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib Esomeprazole 40mg concomitantly, Esomeprazole 40mg before, Regorafenib 160mg or 120mg - Colorectal Neoplasms, Gastrointestinal Stromal Tumors | Phase 4 | Completed | Erasmus Medical Center | 31 | 2016-05-01 | 2018-08-02 |
| Quadripolar Leads for the Management of Heart Failure Patients in the Middle East Electrical optimization by RVLV Conduction Time with VectSelect, Anatomical optimization of device and leads, Implanted device and lead (Cardiac Resynchronization Therapy Defibrillator (CRT-D) device and SJM Quadripolar lead system) - Heart Failure | Phase 4 | Unknown | King Abdullah International Medical Research Center | 389 | 2014-08-01 | 2014-07-21 |
| Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old Prepandrix™, Fluarix™ - Influenza | Phase 4 | Completed | GlaxoSmithKline | 131 | 2012-12-05 | 2018-09-07 |
Cardiomyopathy, Hypertrophic (1) · Colorectal Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Heart Failure (1) · Influenza, Human (1)
Erasmus Medical Center (1) · GlaxoSmithKline (1) · King Abdullah International Medical Research Center (1) · University Health Network, Toronto (1)
Netherlands (1) · South Korea (1)
Azad Mashari, MD (1) · Jacobo Moreno Garijo, MD (1)